MoonLake Immunotherapeutics

MLTXReported to SECin USCIK 0001821586Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 8. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 8
Form 4 lines at MoonLake Immunotherapeutics, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Reich KristianChief Scientific OfficerOpen-market sell$22,0001,100 sharesJul 29, 2026Reich KristianChief Scientific Officer$22,000Sell · Jul 29Open-market sell1,100Jul 29, 2026
Reich KristianChief Scientific OfficerOpen-market sell$48,9602,448 sharesJul 23, 2026Reich KristianChief Scientific Officer$48,960Sell · Jul 23Open-market sell2,448Jul 23, 2026
Reich KristianChief Scientific OfficerOpen-market sell$1,001,00050,000 sharesJul 23, 2026Reich KristianChief Scientific Officer$1,001,000Sell · Jul 23Open-market sell50,000Jul 23, 2026
Reich KristianChief Scientific OfficerOpen-market sell$877,93343,700 sharesJul 21, 2026Reich KristianChief Scientific Officer$877,933Sell · Jul 21Open-market sell43,700Jul 21, 2026
Reich KristianChief Scientific OfficerOpen-market sell$322,26116,105 sharesJul 20, 2026Reich KristianChief Scientific Officer$322,261Sell · Jul 20Open-market sell16,105Jul 20, 2026